Pieper Steven Insider Trading Activity

Average Profitability
20.95%
Insider Buys Quantity
2
Insider Buys Sum
$104,517.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Pieper Steven

According to the SEC Form 4 filings, Pieper Steven, being in a position of

  1. See Remarks at Xeris Biopharma Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 60000 shares for $515,213,
    over all time since 2021-11-10, has bought 53000 shares for $104,518, and sold 60000 shares for $515,213.

Biography of Pieper Steven

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $515,2135100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
5,000
0.0029%
$9.41$47,037+11.46%
2026-09-01SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
5,000
0.0029%
$8.50$42,500+17.5%
2026-08-12SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
5,000
0.0029%
$8.50$42,500+4.83%
2026-07-07SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
27,600
0.0163%
$8.52$235,276-3.08%
2026-07-06SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
17,400
0.0102%
$8.50$147,900+3.58%
2023-11-20PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
28,000
0.0218%
$1.95$54,600+32.42%
2021-11-10PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
25,000
0.0216%
$2.00$49,918+9.47%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.